Proposal of a new limited sampling strategy to predict CYP3A activity using a partial AUC of midazolam
Midazolam metabolic clearance to 1′-hydroxymidazolam is an accurate measure of CYP3A activity which requires extensive plasma and urine sampling. The objective of this study was to find a new limited sampling strategy (LSS) to predict midazolam metabolic clearance to 1′-hydroxymidazolam and subseque...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
3 August 2010
|
| In: |
European journal of clinical pharmacology
Year: 2010, Volume: 66, Issue: 11, Pages: 1137-1141 |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-010-0878-2 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00228-010-0878-2 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00228-010-0878-2 
|
| Author Notes: | Stephanie Katzenmaier, Christoph Markert, Gerd Mikus |
| Summary: | Midazolam metabolic clearance to 1′-hydroxymidazolam is an accurate measure of CYP3A activity which requires extensive plasma and urine sampling. The objective of this study was to find a new limited sampling strategy (LSS) to predict midazolam metabolic clearance to 1′-hydroxymidazolam and subsequently CYP3A activity in an easy and reliable way, reducing costs and labour. |
|---|---|
| Item Description: | Gesehen am 08.03.2023 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1041 |
| DOI: | 10.1007/s00228-010-0878-2 |